Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?

Eur Respir J. 2020 Jul 30;56(1):2001201. doi: 10.1183/13993003.01201-2020. Print 2020 Jul.

Abstract

Insidious venous thromboembolism (VTE) is mainly a problem in ICU-ventilated SARS-CoV-2 patients, while patients in the general ward, treated with thromboprophylaxis (0.5 mg·kg−1), had a low incidence of insidious VTE https://bit.ly/2Yl8jft

Publication types

  • Letter

MeSH terms

  • Aged
  • Betacoronavirus
  • Body Mass Index
  • COVID-19
  • Cohort Studies
  • Coronavirus Infections / complications*
  • Critical Care
  • Female
  • Humans
  • Intensive Care Units
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / complications*
  • Respiration, Artificial / adverse effects*
  • Risk Factors
  • SARS-CoV-2
  • Treatment Outcome
  • Venous Thromboembolism / complications*
  • Venous Thromboembolism / prevention & control*